Clinical Trial Update: Oral Bedtime Melatonin in Critically Ill Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating oral bedtime melatonin in critically ill patients; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest
• Septic Shock
• Stroke
• Stroke Hemorrhagic

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Hospital San Carlos, Madrid | Conditions: Septic Shock, Stroke Hemorrhagic | Phase 4 | Status: UNKNOWN